Research

IUD in hand

Research projects are continuously being developed and implemented within the Family Planning Division. Past and present research includes evaluating the effectiveness and satisfaction of a levonorgestrel-releasing intrauterine system (IUD) for long-term, reversible contraception and the effectiveness of the insertion device. Faculty members within the Obstetrics & Gynecology department have developed a semi-quantitative pregnancy test that is being studied for post-abortion care and in vitro fertilization (IVF) treatment, and a dedicated IUD inserter for use in post delivery settings both domestically and internationally.

Fellowship research projects have included simplifying methods for IUD insertion and improving patient access and experience during 2nd trimester pregnancy termination by evaluating the effectiveness of Mifepristone during treatment.

 

For more information about any current or past research projects or inquiries about potential collaboration or participation, please e-mail: 
familyplanningresearch@stanford.edu

Comparative Study of Menstrual Blood and Systemic Blood: Qualifying the Difference 

The objective of this study is to investigate how menstrual blood differs from systemic blood to evaluate if menstrual blood could be utilized as a natural and non-invasive access to blood for regular health monitoring and early diagnostics. 

This study has not begun recruiting patients. Please email familyplanningresearch@stanford.edu for more information. 

Principal Investigator: Paul Blumenthal, MD, MPH

Labor and Delivery Implant Insertion (LADII): A randomized controlled trial

The objective of this study is to compare the immediate insertion of the contraceptive implant to delayed insertion (before hospital discharge following delivery) and breastfeeding outcomes between timing of insertion.

This study is ongoing and currently recruiting patients presenting to labor and delivery who desire a contraceptive implant for postpartum contraception. Please contact us for more information familyplanningresearch@stanford.edu.

Principal Investigator: Kate A. Shaw, MD, MSc

Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding

The primary objective of this study is to assess the contraceptive efficacy of Mirena beyond 5 years up to 8 years of use. Secondary objectives are the assessment of menstrual blood loss in women who had the Mirena inserted for the indication of heavy menstrual bleeding.

This study is ongoing and actively recruiting patients. Please email familyplanningresearch@stanford.edu for more information.

Principal Investigator: Paul D Blumenthal, MD, MPH

On Demand Contraception: Investigating Efficacy of Ulipristal Acetate plus a COX-2 Inhibitor at Peak Fertility  

The objective of this study is to learn if the combination of Ulipristal Acetate and a COX-2 inhibitor can prevent ovulation (release of an egg) in order to provide more contraceptive (birth control) options to women. 

This study is actively recruiting patients. Please email familyplanningresearch@stanford.edu for more information. 

Principal InvestigatorErica Cahill, MD 

Prospective Multi-Center Office-Based Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception (BLOC) 

The objective of this study is to evaluate the safety and effectiveness of the FemBloc[Symbol] Permanent Contraceptive System for female sterilization in preventing pregnancy and to compare safety and satisfaction measures in women undergoing FemBloc[Symbol] sterilization with women undergoing laparoscopic bilateral tubal sterilization. 

This study is actively recruiting patients. Please email familyplanningresearch@stanford.edu for more information. 

Principal Investigator: Paul Blumenthal, MD, MPH